Showing results (121-130 of 3,692) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|May 22, 2019
A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcomaCongwei Huang, Qinjue Wang, Shengshan Ma, et al.International Journal of Clinical Oncology|March 14, 2022
Oncologic outcomes in elderly patients who underwent hysterectomy for endometrial cancer: a multi-institutional survey in Kinki District, JapanTomohito Tanaka, Suguru Yamashita, Haruo Kuroboshi, et al.International Journal of Clinical Oncology|April 28, 2022
The roles and limitations of bevacizumab in the treatment of ovarian cancerHidekatsu Nakai, Noriomi MatsumuraInternational Journal of Clinical Oncology|April 18, 2022
Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumorsRyugo Teranishi, Tsuyoshi Takahashi, Toshirou Nishida, et al.International Journal of Clinical Oncology|October 11, 2021
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysisTeruki Isobe, Taku Naiki, Yosuke Sugiyama, et al.International Journal of Clinical Oncology|October 18, 2021
Systematic study on expression and prognosis of E2Fs in human colorectal cancerYating Ma, Shijian Wang, Jinfeng Bao, et al.International Journal of Clinical Oncology|October 1, 2021
Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficientKatsuki Miyazaki, Yuji Morine, Shinichiro Yamada, et al.International Journal of Clinical Oncology|January 28, 2022
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)Akio Nakasya, Yuya Hagiwara, Tatsuki Ikoma, et al.International Journal of Clinical Oncology|October 23, 2021
Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancerMasaya Takahashi, Katsuyuki Takahashi, Kazuya Muguruma, et al.International Journal of Clinical Oncology|October 24, 2021
The expression and clinical significance of the tRNA aspartic acid methyltransferase 1 protein in gastric cancerXia Sun, Xianting Huang, Xiangdong Lu, et al.Pageof 370